1. Home
  2. Detail

@nhan_lh.25: #khmer #ghengosoctrang #okombok #ghegomini #xuhuong

NhânLH
NhânLH
Open In TikTok:
Region: VN
Monday 27 October 2025 06:00:57 GMT
3064
48
6
7

Music

Download

No Watermark .mp4 (6.08MB) No Watermark(HD) .mp4 (4.52MB) Watermark .mp4 (8.03MB) Music .mp3

Comments

maingocthai65
រស្មីដួងច័ន្ទ :
bơi cho học viện hả e
2025-10-27 12:34:44
0
daolildara
Đào Lil Đa Ra (thichduthu) :
gửi a video. đi
2025-10-27 22:41:06
0
To see more videos from user @nhan_lh.25, please go to the Tikwm homepage.

Other Videos
YOU SO HANDSOME! 🥵#fyppppppppppppppppppppppp #fyppppppppppppppppppppppp #yousef#putrihokisangjendral
YOU SO HANDSOME! 🥵#fyppppppppppppppppppppppp #fyppppppppppppppppppppppp #yousef#putrihokisangjendral
Tu hate nav jiyana mn Baxtawarm ass 💍♥️ 10/1
Tu hate nav jiyana mn Baxtawarm ass 💍♥️ 10/1
Tomorrow we release Episode 3 of Inside Blood! In this clip, Rob and Calum discuss a major shift in modern health: instead of addressing the quality of the food we eat, society is increasingly turning to pharmaceutical solutions to suppress appetite. GLP-1 drugs such as semaglutide (Ozempic, Wegovy, Mounjaro) highlight this trend, proving that overeating and poor diet are at the root of obesity and Type 2 diabetes, while raising important questions about long-term reliance on medication over lifestyle intervention. In the full episode, we explore: The difference between Type 1 and Type 2 diabetes. Why diet is still the cornerstone of prevention and remission. The role of continuous glucose monitoring and other devices. How new drugs are changing treatment pathways. What lifestyle interventions remain essential despite medical advances. 🎧 Episode 3 launches tomorrow across all platforms. #InsideBlood #Diabetes #Type2Diabetes #MedicalPodcast #Healthspan
Tomorrow we release Episode 3 of Inside Blood! In this clip, Rob and Calum discuss a major shift in modern health: instead of addressing the quality of the food we eat, society is increasingly turning to pharmaceutical solutions to suppress appetite. GLP-1 drugs such as semaglutide (Ozempic, Wegovy, Mounjaro) highlight this trend, proving that overeating and poor diet are at the root of obesity and Type 2 diabetes, while raising important questions about long-term reliance on medication over lifestyle intervention. In the full episode, we explore: The difference between Type 1 and Type 2 diabetes. Why diet is still the cornerstone of prevention and remission. The role of continuous glucose monitoring and other devices. How new drugs are changing treatment pathways. What lifestyle interventions remain essential despite medical advances. 🎧 Episode 3 launches tomorrow across all platforms. #InsideBlood #Diabetes #Type2Diabetes #MedicalPodcast #Healthspan
Outfit check nobody asked for 👀 #OOTD #whocares #fitcheck #fypp
Outfit check nobody asked for 👀 #OOTD #whocares #fitcheck #fypp


About

Legal